Endoscopic removal for nasal and sinus tumors
Part of Cancer, Ear, nose & throat, Lungs & breathing clinical trials.
This trial studies a less invasive way (using an endoscope, a thin tube with a camera) to remove tumors in the nose and sinuses that are in tricky spots. It aims to help patients avoid more invasive open surgery when possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a tumor in your nose, sinuses, or the area at the back of your nose (nasopharynx).
- Your tumor does not extend into the eye socket in a way that would require removal of the eye (orbital exenteration).
- You are medically able to receive general anesthesia (being put to sleep for the procedure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different endoscopic (through the nose) surgical methods to remove growths or lesions in the sphenoid sinus, which is a small air-filled space behind the nose. The goal is to find the best approach for patients whose lesions may extend toward the skull base.
This trial compares two treatments for stage I nasopharyngeal cancer (a type of nasal cancer). It tests whether a minimally invasive surgery (endoscopic surgery) is as good as or better than radiation therapy. It may be an option for people whose cancer is small and hasn't spread to lymph nodes.
This study looks at how well a type of keyhole surgery through the nose works for removing tumors at the base of the skull. It aims to see how much of the tumor can be removed and how patients recover.
This trial tests whether a minimally invasive surgery done through the nose can help people newly diagnosed with early-stage nasopharyngeal cancer. It looks for patients who have not had prior cancer treatment and who are healthy enough for the procedure and follow-up.
This study looks at how doctors manage tumors that start in the nose/sinuses and spread to the skull base. It may help improve planning of care for people with this specific type and location of tumor.
This trial tests a combination of an immunotherapy drug (toripalimab) plus chemotherapy before surgery for sinus cancer that has not spread. The goal is to see if this treatment shrinks the tumor so surgery can be more effective.
Hear when a new Nasal Cavity and Paranasal Sinus Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.